A randomized, double‐blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

BACKGROUND: Studies with the GnRH antagonist ganirelix in assisted reproduction have indicated that compared with traditional GnRH agonist downregulation protocols, slightly fewer oocytes are retrieved. In this study it was investigated whether an increase in the starting dose of recombinant FSH (rF...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human reproduction (Oxford) 2004-01, Vol.19 (1), p.90-95
Hauptverfasser:	Out, Henk J., Rutherford, Anthony, Fleming, Richard, Tay, Clement C.K., Trew, Geoffrey, Ledger, William, Cahill, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Dose-Response Relationship, Drug Double-Blind Method Embryology: invertebrates and vertebrates. Teratology Estradiol - blood Female Follicle Stimulating Hormone - administration & dosage Follicle Stimulating Hormone - adverse effects Follicle Stimulating Hormone - blood follitropin β/ganirelix/GnRH antagonist/RCT/recombinant FSH Fundamental and applied biological sciences. Psychology Gonadotropin-Releasing Hormone - analogs & derivatives Gonadotropin-Releasing Hormone - antagonists & inhibitors Gonadotropin-Releasing Hormone - therapeutic use Hormone Antagonists - therapeutic use Humans Luteinizing Hormone - blood Osmolar Concentration Ovarian Hyperstimulation Syndrome - chemically induced Pregnancy Pregnancy, Ectopic - chemically induced Progesterone - blood Recombinant Proteins - administration & dosage Recombinant Proteins - adverse effects Reproductive Techniques, Assisted
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!